HK1199794A1 - Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto - Google Patents
Processes for the preparation of peripheral opioid antagonist compounds and intermediates theretoInfo
- Publication number
- HK1199794A1 HK1199794A1 HK15100253.5A HK15100253A HK1199794A1 HK 1199794 A1 HK1199794 A1 HK 1199794A1 HK 15100253 A HK15100253 A HK 15100253A HK 1199794 A1 HK1199794 A1 HK 1199794A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- intermediates
- processes
- preparation
- opioid antagonist
- antagonist compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161508817P | 2011-07-18 | 2011-07-18 | |
| PCT/US2012/047082 WO2013012871A1 (en) | 2011-07-18 | 2012-07-17 | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1199794A1 true HK1199794A1 (en) | 2015-07-24 |
Family
ID=47558430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15100253.5A HK1199794A1 (en) | 2011-07-18 | 2015-01-09 | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150045556A1 (es) |
| EP (1) | EP2734041A4 (es) |
| CN (1) | CN103917096A (es) |
| AU (1) | AU2012284127A1 (es) |
| CA (1) | CA2842183A1 (es) |
| HK (1) | HK1199794A1 (es) |
| IL (1) | IL230506A0 (es) |
| IN (1) | IN2014DN00137A (es) |
| WO (1) | WO2013012871A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103804431A (zh) * | 2014-02-25 | 2014-05-21 | 中国人民解放军第四军医大学 | 一种手性二茂铁双膦配体及其制备方法 |
| EP3421455B1 (en) * | 2017-06-29 | 2019-03-27 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Improved process for the preparation of chiral 3-amino-piperidins, useful intermediates for the preparation of tofacitinib |
| AR112467A1 (es) | 2017-08-02 | 2019-10-30 | Vertex Pharma | Procesos para preparar compuestos |
| MX2020005753A (es) | 2017-12-08 | 2020-08-20 | Vertex Pharma | Procesos para producir moduladores de regulador de conductancia transmembranal de fibrosis quistica. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3851081T2 (de) * | 1987-04-16 | 1995-02-16 | Lilly Co Eli | Piperidine als Opioid-Antagoniste. |
| US5536858A (en) * | 1994-02-12 | 1996-07-16 | Hoffmann-La Roche Inc. | Tetrasulfonated diphosphine compounds and metal complexes thereof for asymmetric catalytic reactions |
| US5553858A (en) * | 1995-06-28 | 1996-09-10 | Mckoon; Carl T. | Golf putter |
| US6057456A (en) * | 1997-10-16 | 2000-05-02 | Yale University | Transition metal-catalyzed process for preparing alpha-arylated carbonyl-containing compounds |
| US6900228B1 (en) * | 1998-03-10 | 2005-05-31 | Research Triangle Institute | Opiate compounds, methods of making and methods of use |
| TWI254043B (en) * | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
| US6794510B2 (en) * | 2002-08-08 | 2004-09-21 | Adolor Corporation | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
| RU2512285C2 (ru) * | 2008-12-18 | 2014-04-10 | Ф. Хоффманн-Ля Рош Аг | Способ синтеза производных амино-метилтетралина |
-
2012
- 2012-07-17 WO PCT/US2012/047082 patent/WO2013012871A1/en active Application Filing
- 2012-07-17 CA CA2842183A patent/CA2842183A1/en not_active Withdrawn
- 2012-07-17 EP EP12814994.5A patent/EP2734041A4/en not_active Withdrawn
- 2012-07-17 US US14/233,670 patent/US20150045556A1/en not_active Abandoned
- 2012-07-17 AU AU2012284127A patent/AU2012284127A1/en not_active Abandoned
- 2012-07-17 IN IN137DEN2014 patent/IN2014DN00137A/en unknown
- 2012-07-17 CN CN201280045401.8A patent/CN103917096A/zh active Pending
-
2014
- 2014-01-16 IL IL230506A patent/IL230506A0/en unknown
-
2015
- 2015-01-09 HK HK15100253.5A patent/HK1199794A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2014DN00137A (es) | 2015-05-22 |
| AU2012284127A1 (en) | 2013-05-02 |
| US20150045556A1 (en) | 2015-02-12 |
| CA2842183A1 (en) | 2013-01-24 |
| WO2013012871A1 (en) | 2013-01-24 |
| IL230506A0 (en) | 2014-03-31 |
| EP2734041A1 (en) | 2014-05-28 |
| EP2734041A4 (en) | 2015-03-25 |
| CN103917096A (zh) | 2014-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284407A (en) | Opioid receptor ligands and methods for their use and preparation | |
| IL246265B (en) | A method for the production of intermediates for the preparation of 5-fluoro-h1-pyrazolopyridines and such compounds | |
| ZA201303793B (en) | Substituted quinoline compounds and methods of use | |
| HK1193568A1 (en) | New abuse-resistant pharmaceutical composition for the treatment of opioid dependence | |
| EP2680697A4 (en) | PROCESS FOR PREPARING AN OREXINE RECEPTOR ANTAGONIST | |
| HK1199728A1 (en) | Polymorphic form of pridopidine hydrochloride | |
| EP2787979A4 (en) | MICROSPHERES FOR ADMINISTRATION WITH CONTROLLED OR CONTROLLED RELEASE OF THERAPEUTIC PRODUCTS | |
| EP2640730A4 (en) | METHODS FOR PREPARING EVEROLIMUS AND INTERMEDIATES THEREOF | |
| EP2648519A4 (en) | NEW POLYMORPH OF NILOTINIB HYDROCHLORIDE | |
| EP2630143A4 (en) | PROCESS FOR THE PRODUCTION OF RIVAROXABAN AND INTERMEDIATE PRODUCTS THEREOF | |
| SI2710015T1 (sl) | Polimorf rifaximina in postopek za njegovo pripravo | |
| GB2560284B (en) | Process for the 3-O-demethylation of morphinan compounds | |
| HK1194733A1 (zh) | 製備 -酰基- -苯基磺酰基脯氨酰胺衍生物的方法及中間體 | |
| HK1199794A1 (en) | Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto | |
| ZA201309713B (en) | Process for the preparation of paliperidone | |
| PT2603319E (pt) | Processo para a preparação de uretanos | |
| GB201119690D0 (en) | Process for the preparation of compounds | |
| PL393916A1 (pl) | Sposób wytwarzania związków karbapenamowych | |
| ZA201504676B (en) | An improved process for the preparation of moxifloxacin hydrochloride | |
| PL395425A1 (pl) | Sposób wytwarzania chlorowodorku 2-amino-N-tert-butylo-2- cyjanoacetamidu | |
| ZA201209495B (en) | Novel methods for the preparation of p2x7r antagonists |